ORKA position history
The shares of Oruka Therapeutics (ORKA) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q3: 790,926 shares, $19M, 0.99% of portfolio, New
- 2024 Q4: 352,124 shares, $6.8M, 0.67% of portfolio, Reduce −55.5%
- 2025 Q1: 352,124 shares, $3.6M, 0.69% of portfolio
- 2025 Q2: 352,124 shares, $3.9M, 0.79% of portfolio
- 2025 Q3: 660,424 shares, $13M, 2.9% of portfolio, Add +87.6%
- 2025 Q4: 660,424 shares, $20M, 5.8% of portfolio
- 2026 Q1: 1,520,848 shares, $89M, 11.8% of portfolio, Add +130.3%
- 2026 Q2: 760,424 shares, $72M, 11.6% of portfolio, Reduce −50.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|